The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 05, 2023
Filed:
Sep. 09, 2020
Applicant:
Upm-kymmene Corporation, Helsinki, FI;
Inventors:
Markus Nuopponen, Helsinki, FI;
Lauri Paasonen, Järvenpää, FI;
Anne Meriluoto, Helsinki, FI;
Jukka Rissanen, Kuusisto, FI;
Harri Jukarainen, Kuusisto, FI;
Assignee:
UPM-KYMMENE CORPORATION, Helsinki, FI;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/06 (2006.01); A61P 25/04 (2006.01); A61K 9/00 (2006.01); A61K 31/403 (2006.01); A61K 31/4152 (2006.01); A61K 31/485 (2006.01); A61K 31/541 (2006.01); A61K 47/20 (2006.01); A61K 47/22 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 9/06 (2013.01); A61K 9/0019 (2013.01); A61K 31/403 (2013.01); A61K 31/4152 (2013.01); A61K 31/485 (2013.01); A61K 31/541 (2013.01); A61K 47/20 (2013.01); A61K 47/22 (2013.01); A61K 47/38 (2013.01); A61P 25/04 (2018.01);
Abstract
An injectable pharmaceutical formulation includes nanofibrillar cellulose hydrogel wherein the content of nanofibrillar cellulose in the pharmaceutical formulation is the range of 1-8% (w/w), and pharmaceutical compound. The injectable pharmaceutical formulation can provide a sustained release of a pharmaceutical compound in a subject. Use of nanofibrillar cellulose for preparing the injectable pharmaceutical formulation is also disclosed.